
    
      Prospective, double-blind, placebo-controlled single center pilot study in 23-34 weeks
      gestation premature infants. Study group will receive 1% lactulose, while control group will
      receive 1% dextrose placebo in all their feeds (human milk or preterm formula). Clinical
      parameters will be followed. Stool samples will be sent for culture.
    
  